Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
32466
CAS Number:
6190-39-2
Sal de metanosulfonato de dihidroergotamina
Purity:
≥ 99 % (HPLC)
Synonym(s):
Mesilato de dihidroergotamina
Documents
$88.63 /100 mg
Tamaño
Request Bulk Quote
Product Information

Agonista de los receptores de serotonina vasculares; agonista parcial de los receptores alfa-adrenérgicos y dopaminérgicos D2. Mantener el envase bien cerrado en un lugar seco y bien ventilado.

Synonyms
Mesilato de dihidroergotamina
CAS Number
6190-39-2
Purity
≥ 99 % (HPLC)
Molecular Formula
C33H37N5O5 · CH4O3S
Molecular Weight
679.78
MDL Number
MFCD00058615
PubChem ID
517557
Melting Point
230 - 235 ?C
Appearance
Polvo de color blanco a amarillo claro a rojo claro hasta cristal.
Optical Rotation
[a] D 20 = -17 a -23 ° (C = 0,25, método JP) (calculado sobre sustancia seca)
Conditions
Tienda en RT
General Information
Synonyms
Mesilato de dihidroergotamina
CAS Number
6190-39-2
Purity
≥ 99 % (HPLC)
Molecular Formula
C33H37N5O5 · CH4O3S
Molecular Weight
679.78
MDL Number
MFCD00058615
PubChem ID
517557
Melting Point
230 - 235 ?C
Appearance
Polvo de color blanco a amarillo claro a rojo claro hasta cristal.
Optical Rotation
[a] D 20 = -17 a -23 ° (C = 0,25, método JP) (calculado sobre sustancia seca)
Conditions
Tienda en RT
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Dihydroergotamine methanesulfonate salt is widely utilized in research focused on:

  • Migraine Treatment: This compound is primarily used in the medical field to treat acute migraine attacks. It works by constricting blood vessels in the brain, providing relief to patients who suffer from severe headaches.
  • Vascular Research: In pharmacological studies, it serves as a model compound for understanding vascular responses. Researchers can explore its effects on blood flow and vascular tone, aiding in the development of new cardiovascular therapies.
  • Pharmaceutical Development: The compound is often used in the formulation of medications, allowing scientists to study its stability and efficacy in various delivery systems, such as intranasal or injectable forms.
  • Neuropharmacology: It is utilized in neuropharmacological research to investigate its interactions with serotonin receptors, contributing to the understanding of neurotransmitter systems and potential treatments for other neurological disorders.
  • Clinical Trials: Dihydroergotamine methanesulfonate salt is frequently involved in clinical trials aimed at assessing new therapeutic strategies for migraine and other headache disorders, providing valuable data for future drug approvals.

Citas